Histiocytic and mast cell tumours of uncertain and unknown behaviour Clinical Trials

5 clinical trials for Histiocytic and mast cell tumours of uncertain and unknown behaviour across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Assessment of somatosensory profiles using quantitative sensory testing (QST) in patients with mast cell activation disease (MCAD) — RECRUITING
• A Prospective Non-Interventional Study to Describe the Effectiveness of Avapritinib (BLU-285), a Selective KIT Mutation-Targeted Tyrosine Kinase Inhibitor, in Patients with Indolent Systemic Mastocytosis and Symptoms that are not Adequately Controlled with Symptomatic Treatments in Real-World Setting — RECRUITING
• Registry on data collected from patients with mastocytosis in Europe — RECRUITING
• Registry for BCR-ABL negative myeloproliferative neoplasms — RECRUITING
• Quality of life of patients with systemic mast cell disease before and under basic therapy — OTHER

Refine this search